Strong Price Performance and Market Outperformance
On the day of this record high, Checkpoint Trends Ltd opened with a gain of 4.96%, maintaining this price throughout the trading session and touching an intraday high of Rs.125.9. This performance notably outpaced the broader Sensex, which recorded a modest 0.24% increase on the same day. The stock also outperformed its sector by 4.95%, highlighting its relative strength within Pharmaceuticals & Biotechnology.
The stock has demonstrated consistent gains over the past five trading days, delivering a cumulative return of 27.55% during this period. This streak of consecutive gains has contributed significantly to the stock’s momentum, reinforcing investor confidence in its valuation trajectory.
Long-Term Growth Trajectory
Checkpoint Trends Ltd’s price appreciation over longer horizons is particularly striking. Over the past year, the stock surged by an extraordinary 903.99%, dwarfing the Sensex’s 6.81% gain in the same timeframe. Extending the view further, the company’s five-year return stands at an impressive 5234.75%, compared to the Sensex’s 78.38%. Over a decade, the stock has delivered a staggering 8582.76% increase, far exceeding the Sensex’s 226.41% growth.
These figures illustrate the company’s remarkable ability to generate shareholder value over extended periods, positioning it as a standout performer in the Pharmaceuticals & Biotechnology sector.
Technical Indicators and Moving Averages
From a technical perspective, Checkpoint Trends Ltd is trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment of short-, medium-, and long-term moving averages above current price levels signals a strong bullish trend and sustained investor interest.
The stock’s upward trajectory is further supported by its market capitalisation grade of 4, indicating a solid standing within its market segment. The recent upgrade in its Mojo Grade from Sell to Hold on 4 Sep 2025, accompanied by a Mojo Score of 54.0, reflects an improved assessment of the company’s fundamentals and market position.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Comparative Performance Against Benchmarks
Checkpoint Trends Ltd’s performance over the last three months has been exceptional, with a gain of 152.71%, vastly outperforming the Sensex’s 5.44% increase. Even on a year-to-date basis, the stock has risen by 10.19%, compared to the Sensex’s 0.20% growth, demonstrating resilience and consistent upward momentum.
While the three-year performance shows no change for the stock, the Sensex has advanced by 39.60% in the same period. This anomaly may be attributed to specific corporate actions or market conditions affecting the stock’s price history during that timeframe.
Sector and Industry Context
Operating within the Pharmaceuticals & Biotechnology sector, Checkpoint Trends Ltd’s strong market capitalisation grade and recent price milestones highlight its growing prominence. The sector itself has witnessed varied performance, but the company’s ability to outperform both its sector and the broader market indices consistently marks it as a noteworthy entity.
The company’s Mojo Grade upgrade from Sell to Hold in September 2025 signals a positive shift in its market evaluation, reflecting improved fundamentals or market sentiment. This upgrade, combined with the current Mojo Score of 54.0, positions the stock as a stable holding within its industry context.
Considering Checkpoint Trends Ltd? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Pharmaceuticals & Biotechnology + beyond scope
- - Top-rated alternatives ready
Summary of Key Metrics
Checkpoint Trends Ltd’s market cap grade of 4 and Mojo Score of 54.0, alongside its recent upgrade to Hold, reflect a balanced assessment of its current market standing. The stock’s consistent gains, strong relative performance against benchmarks, and technical indicators all point to a robust market position.
Its five-day consecutive gains culminating in a 27.55% return, combined with a day’s gain of 4.96%, underscore the stock’s strong momentum. Trading above all major moving averages further confirms the positive trend.
Overall, the stock’s achievement of an all-time high at Rs.125.9 on 2 Jan 2026 marks a significant milestone in its market journey, reflecting sustained growth and resilience within the Pharmaceuticals & Biotechnology sector.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →
